Antidiabetic bicyclic compounds

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 59/72 (2006.01) A61K 31/335 (2006.01) A61K 31/352 (2006.01) A61K 31/421 (2006.01) A61K 31/426 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61P 3/10 (2006.01) C07D 213/643 (2006.01) C07D 215/233 (2006.01) C07D 311/58 (2006.01) C07D 333/60 (2006.01) C07D 405/12 (2006.01)

Patent

CA 2667249

Diaryl ethers in which one of the aryl groups is a phenyl fused to a cycloalkyl or heterocyclic ring, to which is attached an acetic acid group, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that often accompany this disease, including insulin resistance, obesity and lipid disorders.

L'invention porte sur des éthers diaryliques dans lesquels l'un des groupes aryle est un phényle fusionné à un cycloalkyle ou à un anneau hétérocyclique lié à groupe d'acide acétique. Lesdits éthers sont des agonistes du récepteur 40 couplé à la protéine G (GPR40) et sont des composés thérapeutiques, particulièrement utiles dans le traitement du diabète sucré de type 2 et des états souvent associés dont la résistance à l'insuline, l'obésité et les troubles lipidiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antidiabetic bicyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidiabetic bicyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic bicyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1890375

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.